Delivery Order SPE2DR25D1100-SPE2DR26FCV9E
- Not listed
- The Defense Logistics Agency awarded a $22,617.45 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Exforge 10-320 mg tablets (30-count). This is a firm fixed-price, non-set-aside contract with a completion date of December 11, 2025, performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Exforge 10-320 mg tablets (30-count) with a ceiling value of $11,442.50. This firm fixed-price delivery order, without a set-aside designation, represents a competitively awarded contract executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a $1,679.83 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Exforge 5-320 mg tablets (30-count). This firm fixed-price contract, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order valued at $2,001.95 to AmerisourceBergen Drug Corp for Exforge 10-320 mg tablets (30-count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Exforge 10-320 mg tablets (30-count packaging) with a ceiling value of $8,065.53 under firm fixed pricing. This non-set-aside, competitively awarded delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Exforge 5-160 mg tablets (30-count units) with a contract ceiling value of $2,250.48. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, leveraging the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,171.24 to AmerisourceBergen Drug Corp for Exforge HCT 10-160-12.5 mg tablets (30-count supply) on September 10, 2025, with completion expected by September 11, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,617.29 to AmerisourceBergen Drug Corp for the supply of Exforge HCT 10-320-25 mg tablets (30-count package). This competitive, firm fixed-price delivery order was issued on December 11, 2025, with an ultimate completion date of December 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its Conshohocken facility. The contract...
- The Defense Logistics Agency awarded a $15,095.94 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Exforge 10-160 mg tablets (30-count units). This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of August 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized for this procurement. This delivery order...
- The Defense Logistics Agency awarded a $3,788.86 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Exforge 10-160 mg tablets (30-count packaging). This is a firm fixed-price delivery order with a completion date of May 13, 2025, and represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCV9EDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,762.79 to AmerisourceBergen Drug Corp for Exforge 10-320 mg tablets (30-count) on December 19, 2025, with a completion date of December 22, 2025. This firm fixed-price delivery order represents a non-competitive award leveraging AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's prime IDC with DLA functions as a comprehensive global pharmaceutical support vehicle enabling delivery of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Department of Defense healthcare programs worldwide. This delivery order for Exforge, an antihypertensive combination medication, exemplifies the routine pharmaceutical supply fulfillments executed under this large-scale contract vehicle supporting military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 12/18/25 |